We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Pioneering Minimally Invasive Technique Promises Safer Heart Valve Procedure

By HospiMedica International staff writers
Posted on 05 Jan 2024
Print article
Image: A minimally invasive technique offer as promising and safe treatment option for patients with severe mitral stenosis (Photo courtesy of Eng, et al., JACC: Cardiovascular Interventions)
Image: A minimally invasive technique offer as promising and safe treatment option for patients with severe mitral stenosis (Photo courtesy of Eng, et al., JACC: Cardiovascular Interventions)

Severe mitral stenosis, which is the narrowing of the valve between the two left heart chambers, is a chronic degenerative process caused due to a build-up of calcium deposits in the mitral valve that is common in elderly patients. Now, findings from a published case series research letter show that severe mitral stenosis can be safely and successfully treated using intravascular lithotripsy (IVL)-enabled percutaneous balloon mitral valvuloplasty. Nevertheless, further extensive studies focusing on high-risk groups are required to validate these preliminary results.

IVL is an innovative technique employed for preparing lesions with severe calcification in coronary and peripheral vessels. This method involves fluid vaporization to create a bubble that expands, emitting sonic pressure waves to break down arterial calcification. For patients with severe mitral stenosis who are ineligible for surgical or other transcatheter interventions, IVL valvuloplasty emerges as a viable alternative. The research letter published by researchers at Henry Ford Health (Detroit, MI, USA) sheds light on the application of IVL in addressing severely calcified mitral valve stenosis. Since their first IVL-enabled mitral valvuloplasty was performed in 2019, the Henry Ford team has now shared their inaugural case series report, detailing the procedure's safety and effectiveness based on 24 cases. The promising safety and efficacy outcomes from this series have boosted the team's confidence in extending this treatment to a broader patient demographic.

“Patients with severely calcified mitral stenosis are often not candidates for conventional open-heart surgery,” said Gennaro Giustino, M.D., a Structural Heart Disease Fellow at Henry Ford Hospital. “This minimally invasive technique pioneered at Henry Ford is a promising and safe treatment option for these patients to improve their cardiac symptoms and quality of life."

Related Links:
Henry Ford Health

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Cannulating Sphincterotome
TRUEtome
New
X-ray Diagnostic System
FDX Visionary-A

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.